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ioannis Sechopoulos7,12, Renata Longo1,2* & christian fedon  7,2
in this study we compared the image quality of a synchrotron radiation (SR) breast computed 
tomography (BCT) system with a clinical BCT in terms of contrast-to-noise ratio (CNR), signal-to-noise 
ratio (SNR), noise power spectrum (NPS), spatial resolution and detail visibility. A breast phantom 
consisting of several slabs of breast-adipose equivalent material with different embedded targets 
(i.e., masses, fibers and calcifications) was used. Phantom images were acquired using a dedicated 
BCT system installed at the Radboud University Medical Center (Nijmegen, The Netherlands) and 
the SR BCT system at the SYRMEP beamline of Elettra SR facility (Trieste, Italy) based on a photon-
counting detector. Images with the SR setup were acquired mimicking the clinical BCT conditions 
(i.e., energy of 30 keV and radiation dose of 6.5 mGy). Images were reconstructed with an isotropic 
cubic voxel of 273 µm for the clinical BCT, while for the SR setup two phase-retrieval (PhR) kernels 
(referred to as “smooth” and “sharp”) were alternatively applied to each projection before tomographic 
reconstruction, with voxel size of 57 × 57 × 50 µm3. The CNR for the clinical BCT system can be up 
to 2-times higher than SR system, while the SNR can be 3-times lower than SR system, when the 
smooth PhR is used. The peak frequency of the NPS for the SR BCT is 2 to 4-times higher (0.9 mm−1 
and 1.4 mm−1 with smooth and sharp PhR, respectively) than the clinical BCT (0.4 mm−1). The spatial 
resolution (Mtf10%) was estimated to be 1.3 lp/mm for the clinical BCT, and 5.0 lp/mm and 6.7 lp/mm 
for the SR BCT with the smooth and sharp PhR, respectively. The smallest fiber visible in the SR BCT 
has a diameter of 0.15 mm, while for the clinical BCT is 0.41 mm. Calcification clusters with diameter 
of 0.13 mm are visible in the SR BCT, while the smallest diameter for the clinical BCT is 0.29 mm. As 
expected, the image quality of the SR BCT outperforms the clinical BCT system, providing images 
with higher spatial resolution and SNR, and with finer granularity. Nevertheless, this study assesses 
the image quality gap quantitatively, giving indications on the benefits associated with SR BCT and 
providing a benchmarking basis for its clinical implementation. In addition, SR-based studies can 
provide a gold-standard in terms of achievable image quality, constituting an upper-limit to the 
potential clinical development of a given technique.
Breast cancer is the leading cause of cancer death in women worldwide1. It is the most diagnosed cancer in 
women, accounting for one-third of all diagnosed cancers2.
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The reference imaging technique for the early diagnosis of breast cancer is 2D digital mammography (DM). 
Recently, digital breast tomosynthesis (DBT), a pseudo 3D breast imaging modality3, has been developed to 
diminish the masking effect and the anatomical noise, showing potential applicability not only in the diagnostic 
domain but also in the screening setting4–6.
Another recent major technological advance is dedicated breast computed tomography (BCT), a fully 3D 
mammographic technique in which multiple low-dose projections are acquired and then reconstructed7,8. BCT 
is a relatively novel technique whose role is starting to be recognized in clinical practice9,10. BCT provides full 3D 
capabilities with adequate soft-tissue differentiation11–15. One of the big challenges for this technique is to com-
bine the high resolution requirements and good lesion detection in a low-dose CT data acquisition16,17.
Presently, a number of dedicated BCT systems with different acquisition modes (e.g., cone-beam11–15, 
parallel-beam18–20, helical-CT16,17,21), imaging techniques (e.g., absorption11–17, phase-contrast18–20,22), and detec-
tor types (e.g., flat-panels11–15,20, photon-counting16–19,21), have been proposed. However, there is no study that 
directly compares the image quality metrics among different systems to date. Therefore, this study aims to provide 
the first quantitative comparison between a clinical BCT system15 and an under-development phase-contrast 
(PhC) synchrotron radiation (SR) BCT system18,19 based on a photon-counting detector, constituting a starting 
point for phantom-based image quality comparisons across different BCT systems.
Medical applications of SR have been successfully proven in both the diagnosis and therapy fields23–26. Of 
note, a PhC SR setup has already been applied in a mammographic clinical study27 demonstrating better image 
quality28 at lower radiation dose and with higher diagnostic power with respect to DM29; other clinically-oriented 
studies on breast-cancer diagnosis are presently underway at different synchrotron facilities30,31. Currently, the 
SYRMA-3D project18,19 at the SR facility Elettra (Trieste, Italy), is developing a PhC BCT system based on SR, 
combining high spatial resolution (by using a single-photon-counting detector32) and low delivered dose (by 
exploiting monochromatic highly-coherent SR). SR-based studies can provide a gold-standard in terms of achiev-
able image quality (i.e., ideal imaging conditions) and they can constitute an upper-limit to the potential clinical 
development of a given technique. At the same time, assessing the difference with clinically available systems 
can provide a benchmark on the current level of behaviour of SR-based techniques, and therefore establish its 
potential for clinical implementation, as well as providing information relevant to the translational research 
aimed at developing compact high-coherence x-ray sources33. In this context, considering the lack of quantitative 
image-quality comparative studies, a comparison with the clinical domain is paramount.
Quantitative metrics such as contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), noise power spec-
trum (NPS), and spatial resolution are useful indicators of image quality, possibly related to diagnostic effective-
ness34. Namely, CNR and SNR are related to low-contrast detail visibility (e.g., glandular tissue embedded in an 
adipose background), the shape of NPS reveals the image texture (i.e., low-frequency-peaked NPS is related to 
coarse image graininess; high-frequency-peaked NPS results in a finer grain noise), and spatial resolution deter-
mines the ability to detect small (high-contrast) details (e.g., microcalcifications).
The comparison between the two systems presented in this study is based on a breast-like phantom containing 
inserts mimicking relevant diagnostic features. The exposure parameters were automatically determined by the 
clinical BCT, while the SR irradiation parameters were tuned to replicate, as close as possible, the clinical condi-
tions in terms of x-ray energy and delivered radiation dose.
Materials and Methods
Phantom. The custom-made breast phantom (design #12-685, CIRS, Norfolk, Virginia, USA) used to per-
form the imaging study is shown in Fig. 1.
The phantom has a semi-ellipsoidal truncated shape consisting of several slabs made of 100% breast-adipose 
equivalent material. A variety of targets are embedded into slab #9 as shown in Fig. 1c: spherical masses of differ-
ent diameters (1.80 mm, 3.18 mm, 4.76 mm and 6.32 mm) made of epoxy resin with density equivalent to breast 
carcinoma; cylindrical fibers of different diameters (0.15 mm, 0.23 mm, 0.41 mm and 0.60 mm); and calcifica-
tion clusters (CaCO3) of different grain sizes (0.13 mm, 0.20 mm, 0.29 mm, 0.40 mm). The lateral size of slab #9, 
ranging from 14 to 15 cm, corresponds to the typical mean breast diameter35. The phantom was positioned at the 
system isocenter both for the clinical BCT (see section 2.2) and for the SR BCT (see section 2.3).
Clinical breast CT system. The dedicated breast CT clinical system14,15,36–38 (Koning Corp., West Henrietta, 
NY) evaluated in this work has a source-to-detector distance of 92.3 cm and a source-to-isocenter distance of 
65.0 cm. The x-ray source (half-cone beam geometry) has a nominal focal spot size of 0.3 mm. The x-ray spectrum 
is tungsten target with aluminium filter set to a fixed voltage of 49 kV for all the acquisitions and a first half value 
layer of 1.39 mm Al (with a mean x-ray energy corresponding to 30.3 keV15, evaluated as the weighted-energy 
average of a photon spectrum model according to the work of Hernandez et al.39, based on air kerma measure-
ments after attenuation by various thickness of Al). The x-ray tube operates in pulse mode, with a constant 8 ms 
pulse length. A complete BCT acquisition consists of 300 projections over a full 360° revolution of the x-ray tube 
and detector in 10 s. The appropriate tube current is selected by acquiring two low-dose projections (16 mA, 2 
pulses of 8 ms each per projection) images at two orthogonal angles (i.e., 0 and 90 degrees).
The detector is a 39.7 cm × 29.8 cm flat-panel detector (4030CB, Varian Medical System, Palo Alto, California, 
USA) with a nominal pixel size of 194 µm, used in 2 × 2 binning mode. Tomographic reconstruction of the images 
is performed by using a Feldkamp-Davis-Kress (FDK)-based algorithm (with a modified Shepp-Logan recon-
struction filter), with isotropic cubic voxels of 273 µm. The main system components and the phantom position 
can be found in the Supplementary Fig. S1. Measurements were performed positioning the phantom at the scan-
ner isocenter.
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The exposure parameter (i.e., the tube current) automatically selected by the clinical BCT for imaging the 
phantom determines the clinical settings and thus the mean glandular dose delivered, to which the SR photon’s 
fluence was tuned.
Synchrotron radiation breast CT setup. The SR BCT system is under development at the SYRMEP 
(SYnchrotron Radiation for MEdical Physics) beamline at the SR facility Elettra (Trieste, Italy), within the frame-
work of the SYRMA-3D project18,19.
The x-ray source of the SYRMEP beamline is produced by a bending magnet of the electron storage ring of 
Elettra. The source-to-detector distance is 31.6 m, while the source-to-isocenter distance is 30.0 m. Given the 
source spatial coherence and the 1.6 m isocenter-to-detector distance, this setup also allows for the exploitation 
of PhC effects, yielding, upon the propagation towards the detector, an increment in contrast across interfaces 
between different materials/tissue types40.
The SR beam is monochromatized by means of a Si (111) double-crystal monochromator providing monoen-
ergetic x rays in the energy range of 9 keV to 40 keV, with an energy resolution ΔE/E = 2 × 10−3. A system of 
tungsten slits is used to define the beam shape, determining a rectangular cross section of 220.0 mm (horizon-
tal)× 3.5 mm (vertical, Gaussian shape, FWHM) at the system’s isocenter (see Supplementary Materials Fig. S2). 
The small vertical dimension of the SR beam requires vertical translations of the patient support to perform fully 
three-dimensional tomographic acquisitions.
A system of calibrated ionization chambers41 provides the air kerma measurements necessary for the 
mean glandular dose evaluation42. The SR BCT system is equipped with a modular CdTe high-efficiency 
photon-counting x-ray imaging detector43 (PIXIRAD-832) encompassing 8 modules covering a global active area 
of 246 × 25 mm2. The detector’s pixels are arranged on a honeycomb matrix with a pitch of 60 µm.
Acquired projection images undergo a detector-specific pre-processing procedure44,45. After data 
pre-processing, a phase-retrieval (PhR) algorithm46 is applied independently to each projection image. From 
a signal processing perspective, PhR is a specific low-pass filter that compensates for high-spatial frequency 
boost due to the free-space-propagation mechanism (i.e., edge enhancement), consequently reducing image 
noise47. As most low-pass filters, PhR can be tweaked to reach different trade-offs between image noise and spa-
tial resolution48. As previously reported, phase-retrieval filters with two different parameter sets are applied to 
synchrotron-based images privileging either noise reduction or spatial resolution48,49. These two approaches are 
referred to smooth- and sharp-kernel PhR, corresponding to single (i.e., value of the parameter δ/β = 2267) and 
two materials (i.e., value of the parameter δ/β = 795), respectively, as specified in the work of Brombal et al.48.
Following the PhR procedure, projections are reconstructed via Filtered Back Projection (FBP) with 
Shepp-Logan filtering50 implemented via Graphics Processing Unit (GPU). Given the pixel’s honeycomb geom-
etry and the slight magnification due to the beam divergence the reconstructed voxel size is 57 × 57 × 50 µm3.
Measurements were performed positioning the phantom at the system isocenter (see Supplementary Materials 
Fig. S2). The energy was set to 30 keV in order to match the average energy of the clinical BCT14,15, and the flu-
ence was adjusted by means of aluminium filters to replicate the clinical dose level. Slab #9 was scanned in three 
vertical steps by acquiring 1200 projections over an angle of 180° per step, resulting in an overall scan time of 
approximately 100 s.
Figure 1. (a) Photograph of the phantom and (b) phantom dimensions [in mm]. (c) Details embedded in slab 
#9: calcifications (CaCO3) in red circles, masses in blue stars and fibers in green rectangles. The drawings are not 
to scale.
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Image quality analysis. The contrast-to-noise ratio (CNR) is defined by the ratio of the (average) pixel 
intensity difference between the  detail signal and the background ( Iobject − Ibkgd), and the standard deviation 









Of note, the standard deviation of the background is assumed to represent the magnitude of the image noise 
(i.e., noise is assumed to be ergodic).
With reference to the previous definition, CNR does not capture the dependence of detail visibility on the 
detail’s size (i.e., Rose criterion). Therefore, the signal-to-noise ratio (SNRRose) metric can be introduced52,53:
= ×SNR CNR N (2)Rose pixel
where CNR is defined as in Eq. (1) and Npixel is the number of pixels of the selected region of interest (ROI) within 
a given detail. For the sake of simplicity, hereafter the SNRRose is referred to as SNR. Both CNR and SNR were 
evaluated for all the spherical masses shown in Fig. 1c. For each mass a circular ROI with a diameter scaling with 
the mass dimension was selected within the detail, while, for the background estimation, 10 evenly spaced ROIs 
were selected in the neighbouring region (Fig. 2a), and the standard deviation was selected to be the average value 
of the background ROIs’ standard deviations. In the case of synchrotron-based datasets this analysis was repeated 
also by averaging 5 consecutive slices in order to match (as close as possible) the slice thickness of the clinical 
system, resulting in an effective voxel size of 57 × 57 × 250 μm3. With this choice a similar volume of a given detail 
is considered in each transverse slice for both systems.
While both CNR and SNR depend on the magnitude of the background noise, the image texture (or grain-
iness) is characterized by the noise power spectrum (NPS), which is the noise spectral decomposition in the 
Fourier space. The in-slice NPS is a bi-dimensional map in Fourier space and it is measured from a homogeneous 















where fx, fy are the spatial frequencies, dx, dx are the pixel sizes (mm) in x and y dimension, Nx, Ny are the corre-
sponding ROI dimensions measured in number of pixels, NROI is the number of selected ROIs,   denotes the 
bi-dimensional Fourier transform, Ii (x, y) is the pixel value at position (x, y) of the i-th ROI and Pi (x, y) is a 2nd 
order polynomial fit of Ii (x, y). The subtraction with the polynomial term Pi (x, y) is a practical implementation 
of the de-trending procedure, aiming at removing any slowly-varying nonuniformities that may be caused from 
beam hardening effects, scattered radiation or nonuniform detector gain55,56.
As NPS is a spectral decomposition of image noise (σ), we have:
σ = ∬ ( )NPS f f df df, (4)x y x y2
Following the procedure described by Solomon et al.55, in order to compare only noise textures of images with 
different noise magnitudes, the normalized NPS (nNPS) is defined as:
σ
=( )nNPS f f NPS f f, ( , ) (5)x y x y2
Figure 2. (a) Region of interest position for the contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR) 
evaluation. (b) Region of interest position for the noise power spectrum (NPS) evaluation in a homogeneous 
background.
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In addition, since NPS maps of tomographic reconstructions usually show circular symmetry, it is common to 
show one-dimensional radially averaged NPS curves making use of the identity = +f f fr x y
2 2 .
The nNPS distributions, both bi- and mono-dimensional, were evaluated for both systems by selecting 20 
evenly spaced square ROIs at a constant distance from the phantom center as shown in Fig. 2b.
Given the difference in the reconstructed voxel size between the two systems, the used ROIs have a 64 × 64 
pixels area for the clinical and system 256 × 256 pixels area for the synchrotron datasets, meaning that each ROI 
represents a similar physical area for both systems.
The uncertainty on radial nNPS curves was assessed by repeating the measure in 10 different homogeneous 
slices and associating, for each spatial frequency, the corresponding standard deviation56.
The spatial resolution of both systems was estimated starting from the reconstructed images by using a rather 
novel approach introduced by Mizutani et al.57, which is based on a logarithmic intensity plot in the Fourier 
domain, and it has shown consistent results for both planar and tomographic applications58. The main advantage 
of this technique is that it allows to estimate spatial resolution directly from general sample images, not requiring 
dedicated phantoms, under the hypothesis of a Gaussian system point spread function (PSF). Although modern 
digital detectors, especially direct conversion devices, in general do not feature Gaussian response functions, the 
whole imaging chain PSF contains also the contribution of each processing step leading to the final tomographic 
image. In particular, both the interpolation and the apodization filter inherent to tomographic reconstruction 
contribute to smoothen the system PSF59, usually described by a bell-shaped curve which, in the case of the 
presented technique, is approximated by a Gaussian function. Under this assumption, the full width at half max-
imum (FWHM) of the PSF can be determined from the following equation:
 π≅ − +I x y FWHM f constantln [ ( , )]




where I x y[ ( , )]r  is the radially averaged Fourier transform of the image I(x,y). As input image I(x,y), a wide 
square ROI enclosed within the uniform region of the phantom was selected, then  I x yln [ ( , )]r
2 was plotted as 
function of fr
2 and a low-frequency linear region was identified. According to Eq. (6) the slope of this region, 
extracted by a linear regression, is proportional to the square of the FWHM of the image PSF. Once the FWHM 
of the Gaussian PSF is known, the spatial resolution corresponding to the 10% of the modulation transfer func-
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The presence of the factor 1.24 in the previous formula is justified in the Supplementary Materials (Eqs. ( SE1) 
to ( SE5)).
All the aforementioned quantitative analyses were performed developing a computer code in MATLAB (The 
MathWorks, Natick, MA, USA).
In addition, a qualitative analysis on the visibility of high-resolution details (i.e., calcification clusters and 
fibers) was performed by comparing the tomographic reconstructions of both setups.
Results
The tube current automatically selected by the clinical BCT system for the breast phantom was 50 mA (for the 
49 kV spectrum with a mean x-ray energy corresponding to 30.3 keV). This tube current value leads to an air 
kerma of 10.7 mGy and to a mean glandular dose15 of 6.5 mGy, for a breast diameter of 14 cm and a glandular 
fraction of 0%.
For the SR BCT, the air kerma was 14.2 mGy, corresponding to a radiation dose (i.e., MGDv parameter evalu-
ated according to Mettivier et al.42) of 6.7 mGy for a 14 cm breast diameter and a glandular fraction of 0%.
Quantitative metrics (SNR, CNR, NPS and spatial resolution). Figure 3a shows the CNR values as a 
function of mass dimension for the two BCT systems (red colour for the clinical one and blue colour for the SR). 
In the case of SR images, the two PhR kernels and the two slice approaches (i.e., single slice and average over 5 
consecutive slices to match the clinical slice thickness) are reported.
The CNR in the clinical BCT system is higher than in the SR case, regardless of the reconstruction and/or 
averaging methods: this is mainly due to the difference in the reconstructed voxel size. It has to be noted that 
an edge artifact in the phantom’s periphery involves the 6.32 mm mass leading to higher CNR, (see Fig. S3 in 
Supplementary Materials).
On the contrary, considering the detail visibility (Fig. 3b), which accounts for the number of pixels enclosed 
within the detail of interest, the synchrotron data show superior performance in all configurations, yielding, in 
case of the smooth PhR kernel and slice averaging, a 2.5 to 3 times higher SNR for all mass diameters.
Figure 4(a–c) show the bi-dimensional nNPS distributions for the clinical system and SR images with smooth 
and sharp PhR kernels. The noise in the clinical system is much coarser than in SR images, as visible in the upper 
insets of Fig. 4(a–c). Given the circular symmetry of bi-dimensional nNPS, their radial profiles were computed 
and plotted in Fig. 4d.
Peak frequencies largely differ when comparing the two systems, being 0.4 mm−1 for the clinical BCT, 
0.9 mm−1 and 1.4 mm−1 for the synchrotron images reconstructed with smooth and sharp PhR, respectively. 
In addition, the nNPS drops to 5% of its maximum value at 1 mm−1 for clinical images, and at 5–6 mm−1 for SR 
datasets meaning that the roll-off slopes of nNPS curves are substantially different.
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Figure 3. (a) Contrast-to-noise ratio and (b) signal-to-noise ratio as a function of mass diameter for the clinical 
breast CT (red solid line) and synchrotron breast CT with smooth (blue dashed lines) and sharp (blue solid 
lines) phase-retrieval kernels. Of note, in both plots, the point relative to the largest mass scanned with the 
clinical system produces a higher-than-expected CNR/SNR due to a reconstruction artifact (see Supplementary 
Materials Fig. S3).
Figure 4. Bi-dimensional normalized noise power spectra (nNPS) for (a) the clinical BCT system, synchrotron 
BCT with (b) smooth and (c) sharp phase-retrieval algorithm. Of note, the range of frequency axes in (a) is 
different from (b,c). The inset on the top-left corner of each image represent the same homogeneous ROI with 
an area of 20×20 mm2. (d) Radial averaged nNPS for the clinical system (dashed red line), and SR breast CT 
with smooth (dashed blue line) and sharp (solid blue line) phase-retrieval algorithm. Of note, the left y-axis 
refers to the nNPS of the clinical system, while the right y-axis to the synchrotron breast CT. The shaded region 
around each line represents one standard deviation uncertainty.
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The spatial resolution is estimated as shown in Fig. 5: a linear region at small spatial frequencies is identified 
for all the datasets, where steeper linear fits indicate worse spatial resolutions.
From the linear regressions (Eq. (6)), the spatial resolutions were estimated to be 0.61 mm (FWHM) or 1.3 lp/
mm (MTF10%) for the clinical BCT, and 0.16 mm or 5.0 lp/mm (MTF10%) for the smooth PhR and 0.12 mm or 6.7 
lp/mm (MTF10%) for the sharp PhR in SR images. The quantitative analysis results are summarized in Table. 1.
Qualitative analysis on lesion detectability. Figure 6(a–l) display the epoxy fibers reconstructed from 
the clinical (a–d) and SR datasets with smooth (e–h) and sharp (i–l) PhR kernels. All the fibers are visible in the 
SR-based images regardless of the used PhR kernel, while the two smallest fibers (0.23 mm and 0.15 mm in diam-
eter) are not distinguishable in clinical BCT images.
Figure 7(a–l) show image details of the calcification clusters for the clinical (a–d) and SR datasets with smooth 
(e–h) and sharp (i–l) PhR kernels. For the clinical BCT system, no calcification cluster with diameter below 
0.20 mm can be properly identified, while in the case of SR breast CT the smallest calcifications (0.13 mm in 
diameter) represent the visibility limit for both the smooth and sharp PhR kernels.
Discussion
The proposed image quality analysis assessed the gap in image quality between the PhC SR BCT setup and the 
clinical BCT system.
Figure 5. Evaluation of the spatial resolution for the clinical system (red circles), and synchrotron breast CT 
with smooth (blue squares) and sharp (blue-white triangles) phase-retrieval algorithm. The logarithm of the 
squared absolute value of the image Fourier transform (on y-axis) is plotted as function of the square of the 
spatial frequency (on x-axis). The linear fit for each dataset is shown with black lines. The inset displays a zoom 








Clinical BCT 5.2 48 0.4 0.61 1.3
SR smooth 
PhR
2.3 (1 slice) 105
0.9 0.16 5.0
3.0 (5 slices) 135
SR sharp PhR
1.2 (1 slice) 55
1.4 0.12 6.7
1.7 (5 slices) 76
Table 1. Summary of the comparison analysis between the two systems: clinical BCT and synchrotron 
radiation (SR) datasets (with smooth and sharp phase-retrieval (PhR) kernel). The table reports the values 
for contrast-to-noise ratio (CNR) and signal-to-noise ratio (SNR) for the 4.76 mm diameter mass, the peak 
frequency of the normalized noise power spectrum (nNPS), full width at half maximum (FWHM) of the 
estimated point spread function (PSF) and modulation transfer function at 10% (MTF10%). CNR and SNR are 
measured by selecting 1 slice and the average of 5 slices, while the other values can be found in Supplementary 
Materials (Tab. S1).
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Figure 6. Details of the fibers reconstructed (a–d) with the clinical BCT system, (e–h) smooth and (i–l) sharp 
phase-retrieval (PhR) kernels for the synchrotron BCT. The scale reference is reported on the upper right corner 
of image (a).
Figure 7. Details of the calcification clusters reconstructed (a–d) with the clinical BCT system, (e–h) smooth 
and (i–l) phase-retrieval (PhR) kernels for the synchrotron BCT.
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In terms of detail visibility, the smallest fibres (i.e., diameter of 0.15 mm) and calcification clusters (i.e., diam-
eter of 0.13 mm) are visible in the SR BCT, while details below 0.20 mm cannot be identified in the clinical BCT 
system (Figs. 6 and 7).
The CNR for the SR breast CT is found to be (as a first approximation) constant for different mass dimensions, 
with small fluctuations mainly due to different noise levels (Fig. 3a). In particular, the two masses (diameters of 
3.18 mm and 4.76 mm) positioned closest to the center of the phantom show a slightly lower CNR with respect to 
the two located in the phantom’s periphery: this behaviour is compatible with the usual radial noise dependence 
observed in CT reconstructions (i.e., higher noise in the center, lower noise in the periphery). In agreement with 
results published in previous studies48,49, the smooth-kernel PhR yield a 2-fold higher CNR with respect to the 
sharp-kernel PhR. As mentioned, the higher CNR value observed for the mass of 6.32 mm in the clinical BCT 
images is caused by a reconstruction artifact close to the phantom’s edge where the mass is located (as reported in 
Supplementary Materials Fig. S3).
The SNR for the SR setup can be up to 3-times higher with respect to the clinical BCT if the smooth recon-
struction kernel is used when the average of 5 slices is considered, or more than 2-times higher if no averag-
ing is performed (Fig. 3b). This difference can be mainly attributed to the high-efficiency and low-noise of the 
photon-counting detector, to the presence of phase-contrast effects, which allows the phase-retrieval filter to be 
applied, and to the higher dose-efficiency of the synchrotron system due to the beam monochromaticity. In addi-
tion, thanks to the laminar shape of the beam and the large isocenter-to-detector distance, the SR setup allows to 
obtain inherently scatter-free images.
Considering SR-based data, it should be noted that, if the noise of each slice was uncorrelated, the expected 
SNR/CNR increase due to the averaging of 5 slices would be of a factor 5 , whereas the observed factor is much 
smaller (between 1.3 and 1.4). This is mainly related to the application of the phase-retrieval that, being a 2D filter 
in the projections domain introduces a certain degree of correlation also between neighbouring pixels belonging 
to different rows of pixels, hence to different slices.
The nNPS evaluation revealed that the synchrotron images have a 2 to 4-times higher peak frequency (for the 
sharp phase-retrieval kernel, respectively) and a generally shallower roll-off slope, meaning that the contribution 
to the image noise is not negligible up to 6 mm−1, to be compared with 1 mm−1 of the clinical system’s case. It is 
worth noticing that the peak frequency for the clinical BCT (i.e., 0.4 mm−1) is consistent with previous findings 
of Betancourt-Benitez et al.37.
The observed differences in terms of nNPS between clinical and synchrotron data reveals that the SR setup 
imaging chain (i.e. detector, image processing and tomographic reconstruction) provides generally sharper or, 
equivalently, less correlated noise: this is ultimately related to the smaller detector pixel size and to the higher 
image-sharpness offered by direct-conversion photon-counting detectors.
Spatial resolution was estimated by using a rather novel technique that can be applied, in principle, to any 
tomographic image (under the approximation of a Gaussian-shaped system PSF), thus not needing a specifi-
cally designed phantom. Of note, since system PSFs are not in general described exactly by a Gaussian func-
tion, this method cannot fully replace the direct PSF and MTF measurements based on line-patterns or small 
high-absorbing details, but has to be regarded as a fast and easy way to provide a spatial resolution estimate or to 
be used for routine checks. The results obtained on the SR images, with both the smooth and sharp PhR kernels, 
are compatible with conventional spatial resolution estimates (based on the edge spread function technique) 
documented in previous studies49,61.
Remarkably, the spatial resolution estimated for clinical BCT through the Fourier space linear regression 
method (i.e., 1.3 lp/mm) is in reasonable agreement to the value found by Betancourt-Benitez et al.38 (i.e., ~1.1 lp/
mm), by using the conventional tungsten-wire procedure.
Quantitatively, the spatial resolution of the SR system was found to be 4 to 5 times better than the clinical 
system (5 to 7 lp/mm for the synchrotron to be compared with 1.3 lp/mm for the clinical setup). Interestingly, 
synchrotron images outperform every clinical breast CT setup reported in literature so far8 in terms of spatial 
resolution, the maximum being 5 lp/mm for a photon-counting BCT system proposed by Kalender et al.16,17,21.
Nevertheless, it should be noted that the implementation of SR BCT to the clinical realm presents also some 
practical drawbacks. Besides the fact that SR facilities are limited in number, not allowing access to a wide pop-
ulation, SR BCT requires in general a longer scan time with respect to clinical systems due to the limited vertical 
dimension of the beam and to the need for patient rotation. This may lead to motion artifacts due to both volun-
tary and involuntary movements of the patient, possibly impairing image quality (mainly spatial resolution). This 
issue has been investigated also in a clinical context suggesting the use of a breast immobilizer62. In addition, the 
SYRMA-3D collaboration is devoting several efforts towards the reduction of the scan time, aiming to complete 
the examination in about 5 minutes19.
The metrics used in this work allow to show differences in terms of physical performances of the systems 
but not in their clinical impact (i.e., breast cancer detection and diagnosis), which should be evaluated through 
dedicated studies.
Of note, the selected SR beam energy replicates the average-output energy of the x-ray spectrum of the 
clinical BCT system without considering the effective energy shift due to beam hardening effect through the 
sample. However, recent results63 have shown that CNR, evaluated in glandular details embedded in a adipose 
background and fixed dose, has small variations (i.e., few percent) in the energy range between 30 and 37 keV, 
which includes the effective energy of the hardened spectrum for the clinical system.
Lastly, it should be stressed that, albeit SR BCT images rely not only on absorption contrast but also on phase 
effects, the application of the phase-retrieval algorithm produces images whose content describes the absorption 
properties of the sample47,64.
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conclusions
This study compares the image quality difference between a BCT synchrotron radiation set-up using a 
photon-counting detector and a clinical BCT system. As expected, synchrotron-based images feature higher spa-
tial resolution, SNR, and finer granularity; providing, for the first time, a quantitative assessment of this image 
quality gap.
It is clear that, despite offering remarkable performances, a widespread diffusion of SR BCT is not feasible 
in terms of costs and infrastructural requirements. In any case, SR-based studies can provide a gold-standard in 
terms of achievable image quality, constituting, in practice, an upper-limit to the potential clinical development 
of a given technique. Moreover, a direct assessment of the image quality improvements due to the use of synchro-
tron in comparison with commercially available setups is needed to substantiate the effort required to implement 
the BCT clinical program at Elettra synchrotron radiation facility. At the same time, the ongoing development of 
synchrotron-like compact x-ray sources may open up the possibility of exploiting the same techniques investi-
gated in synchrotron facilities on a much wider domain.
Data availability
The dataset analysed and discussed in the current study are available contacting the corresponding author on 
reasonable request.
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